Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
To the editor: In recent years, molecular imaging with [18F]fluorodeoxyglucose (FDG) and several other new radiolabelled compounds by positron emission tomography (PET) has made a valuable impact in various clinical arenas, primarily within the field of oncology. However, PET has also made valuable contributions in other areas and a recent article in Heart by Knuuti and Bengel1 highlights the critical …
Competing interests: None.